129 related articles for article (PubMed ID: 37506532)
21. Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus.
Raynaud C; Daher W; Roquet-Banères F; Johansen MD; Stec J; Onajole OK; Ordway D; Kozikowski AP; Kremer L
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32041716
[TBL] [Abstract][Full Text] [Related]
22.
Aragaw WW; Cotroneo N; Stokes S; Pucci M; Critchley I; Gengenbacher M; Dick T
Microbiol Spectr; 2022 Feb; 10(1):e0132121. PubMed ID: 35019671
[TBL] [Abstract][Full Text] [Related]
23. Dual Inhibition of
Choi SR; Britigan BE; Narayanasamy P
ACS Infect Dis; 2019 Sep; 5(9):1559-1569. PubMed ID: 31264851
[TBL] [Abstract][Full Text] [Related]
24. Iron/Heme Metabolism-Targeted Gallium(III) Nanoparticles Are Active against Extracellular and Intracellular
Choi SR; Britigan BE; Narayanasamy P
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30782994
[TBL] [Abstract][Full Text] [Related]
25. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
[No Abstract] [Full Text] [Related]
26. Aspergillus fumigatus Preexposure Worsens Pathology and Improves Control of Mycobacterium abscessus Pulmonary Infection in Mice.
Monin L; Mehta S; Elsegeiny W; Gopal R; McAleer JP; Oury TD; Kolls J; Khader SA
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263106
[TBL] [Abstract][Full Text] [Related]
27. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
Pryjma M; Burian J; Thompson CJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
[No Abstract] [Full Text] [Related]
28. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
[TBL] [Abstract][Full Text] [Related]
29. Thiostrepton: A Novel Therapeutic Drug Candidate for
Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481
[No Abstract] [Full Text] [Related]
30. Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen Mycobacterium abscessus.
Casanova M; Maresca M; Poncin I; Point V; Olleik H; Boidin-Wichlacz C; Tasiemski A; Mabrouk K; Cavalier JF; Canaan S
J Biomed Sci; 2024 Jan; 31(1):18. PubMed ID: 38287360
[TBL] [Abstract][Full Text] [Related]
31. Disulfiram Is Effective against Drug-Resistant Mycobacterium abscessus in a Zebrafish Embryo Infection Model.
Winters CG; Basnet RM; Faasuamalie PE; Shallom SJ; Zelazny AM; Gupta S; Olivier KN
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0053922. PubMed ID: 36197094
[TBL] [Abstract][Full Text] [Related]
32. Mycobacterium abscessus Cells Have Altered Antibiotic Tolerance and Surface Glycolipids in Artificial Cystic Fibrosis Sputum Medium.
Hunt-Serracin AC; Parks BJ; Boll J; Boutte CC
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010859
[No Abstract] [Full Text] [Related]
33. Outcomes of pulmonary
Flight WG; Hough NE; Chapman SJ
Int J Mycobacteriol; 2020; 9(1):48-52. PubMed ID: 32474488
[TBL] [Abstract][Full Text] [Related]
34.
Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
[TBL] [Abstract][Full Text] [Related]
35. Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against
Moore JE; Koulianos G; Hardy M; Misawa N; Millar BC
Int J Mycobacteriol; 2018; 7(3):265-267. PubMed ID: 30198508
[TBL] [Abstract][Full Text] [Related]
36.
Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
[No Abstract] [Full Text] [Related]
38.
Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
[TBL] [Abstract][Full Text] [Related]
39. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.
Kirkwood ZI; Millar BC; Downey DG; Moore JE
Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035
[TBL] [Abstract][Full Text] [Related]
40. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]